Dr. Lal PathLabs Ltd (LALPATHLAB) Q4FY26 Management Mirror - Mar-2026 Qtr
Revenue & Volumes
Management initiated FY27 revenue growth guidance at 13% to 15% (early to mid-teens) alongside expectations for marginally improved patient volume growth driven by network expansion, advancing from the FY26 organic revenue growth target of 11% to 12% that was consistently maintained through the Sep'25 Qtr and Dec'25 Qtr. [Status: Initiated]
4 more themes on the ELITE plan.